MOSUNETUZUMAB for Diffuse large b-cell lymphoma stage iv: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 29 adverse event reports in the FDA FAERS database where MOSUNETUZUMAB was used for Diffuse large b-cell lymphoma stage iv.
Most Reported Side Effects for MOSUNETUZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Cytokine release syndrome | 96 | 19.0% | 7 | 74 |
| Disease progression | 65 | 12.9% | 17 | 4 |
| Covid-19 | 50 | 9.9% | 8 | 26 |
| Neutropenia | 39 | 7.7% | 4 | 7 |
| Death | 38 | 7.5% | 38 | 2 |
| Covid-19 pneumonia | 37 | 7.3% | 16 | 35 |
| Malignant neoplasm progression | 37 | 7.3% | 26 | 2 |
| Disorientation | 31 | 6.1% | 31 | 0 |
| Neurological symptom | 31 | 6.1% | 31 | 0 |
| Vasogenic cerebral oedema | 31 | 6.1% | 31 | 0 |
| Pneumonia | 30 | 5.9% | 14 | 15 |
| Off label use | 29 | 5.7% | 18 | 2 |
| Diffuse large b-cell lymphoma recurrent | 28 | 5.5% | 28 | 0 |
| Therapy partial responder | 26 | 5.1% | 25 | 0 |
| Pyrexia | 23 | 4.6% | 2 | 12 |
Other Indications for MOSUNETUZUMAB
B-cell lymphoma (158)
Follicular lymphoma (144)
Non-hodgkin's lymphoma (54)
Diffuse large b-cell lymphoma (46)
Chronic lymphocytic leukaemia (21)
Non-hodgkin's lymphoma unspecified histology indolent (20)
Product used for unknown indication (15)
Follicular lymphoma recurrent (8)
Follicular lymphoma refractory (6)
Non-hodgkin's lymphoma metastatic (6)
Other Drugs Used for Diffuse large b-cell lymphoma stage iv
RITUXIMAB (1,392)
CYCLOPHOSPHAMIDE (1,222)
DOXORUBICIN (1,117)
VINCRISTINE (1,094)
PREDNISONE (725)
ETOPOSIDE (339)
CYTARABINE (315)
EPCORITAMAB (311)
PREDNISOLONE (311)
METHOTREXATE (289)